FindTrial
Sign In

Quality of Life (QOL) Questionnaires

OTHER5 trials

Sponsors

Celgene, University of California, San Francisco, Thomas Martin, MD

Conditions

Advanced Malignant Solid NeoplasmBeta-ThalassemiaCancerGastrointestinal CancerGynecologic CancerHead and Neck CancerHematopoietic and Lymphoid Cell NeoplasmLocally Advanced Malignant Solid Neoplasm

Phase 1

CRISPR Delivered Anti-BCMA Car-T Therapy for Relapsed or Refractory Multiple Myeloma
RecruitingNCT07340853
Thomas Martin, MDMultiple Myeloma, Recurrent Multiple Myeloma, Refractory Multiple Myeloma
Start: 2026-02-28End: 2043-05-25Target: 30Updated: 2026-03-10

Unknown Phase

To Document the Burden of Illness on the Quality of Life and the Impact on Healthcare Utilization in (Beta) β-thalassemia Subjects Who Are Transfusion Dependent (TD) and Non-transfusion Dependent (NTD) Receiving Standard of Care
CompletedNCT02626689
CelgeneBeta-Thalassemia
Start: 2016-03-01End: 2017-01-03Updated: 2017-04-07
Integrative Palliative Care/Psycho-Oncology Telehealth Intervention in Patients With Advanced Cancer
CompletedNCT04697524
University of California, San FranciscoAdvanced Malignant Solid Neoplasm, Locally Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm
Start: 2021-01-26End: 2023-05-31Updated: 2023-08-15
Study of Attention and Memory Treatments for Cancer Survivors
CompletedNCT04870320
University of California, San FranciscoHematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm
Start: 2021-03-01End: 2022-01-31Updated: 2022-04-08
Fatigue and Molecular Mechanisms in Cancer Patients Receiving CCRT
RecruitingNCT06633224
University of California, San FranciscoCancer, Gastrointestinal Cancer, Gynecologic Cancer +2
Start: 2024-12-27End: 2027-09-01Target: 125Updated: 2025-09-16